Celldex Therapeutics to Participate in the Jefferies 2017 Global Healthcare Conference
The live webcast will be available on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. A replay will be available for seven days following the event.
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline includes antibodies, antibody-drug conjugates and other protein-based therapeutics derived from a broad set of complementary technologies which have the ability to engage the human immune system and/or directly inhibit tumors to treat specific types of cancer or other diseases. Visit www.celldex.com.
Sarah CavanaughVice President of Investor Relations & Corp Communications Celldex Therapeutics, Inc.(781) 433-3161 email@example.com Charles LilesAssociate Director of Investor Relations & Corp Communications Celldex Therapeutics, Inc.(781) 433-3107 firstname.lastname@example.org
News Provided by Acquire Media